Literature DB >> 24872415

N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.

Maiken Mellergaard1, Sarah Line Skovbakke1, Christine L Schneider2, Felicia Lauridsen1, Lars Andresen1, Helle Jensen1, Søren Skov3.   

Abstract

NKG2D is an activating receptor expressed on several types of human lymphocytes. NKG2D ligands can be induced upon cell stress and are frequently targeted post-translationally in infected or transformed cells to avoid immune recognition. Virus infection and inflammation alter protein N-glycosylation, and we have previously shown that changes in cellular N-glycosylation are involved in regulation of NKG2D ligand surface expression. The specific mode of regulation through N-glycosylation is, however, unknown. Here we investigated whether direct N-glycosylation of the NKG2D ligand MICA itself is critical for cell surface expression and sought to identify the essential residues. We found that a single N-glycosylation site (Asn(8)) was important for MICA018 surface expression. The frequently expressed MICA allele 008, with an altered transmembrane and intracellular domain, was not affected by mutation of this N-glycosylation site. Mutational analysis revealed that a single amino acid (Thr(24)) in the extracellular domain of MICA018 was essential for the N-glycosylation dependence, whereas the intracellular domain was not involved. The HHV7 immunoevasin, U21, was found to inhibit MICA018 surface expression by affecting N-glycosylation, and the retention was rescued by T24A substitution. Our study reveals N-glycosylation as an allele-specific regulatory mechanism important for regulation of surface expression of MICA018, and we pinpoint the residues essential for this N-glycosylation dependence. In addition, we show that this regulatory mechanism of MICA surface expression is likely targeted during different pathological conditions.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Genetic Polymorphism; Glycosylation; Herpesvirus; Innate Immunity; Melanoma; Natural Killer Cells (NK Cells)

Mesh:

Substances:

Year:  2014        PMID: 24872415      PMCID: PMC4106324          DOI: 10.1074/jbc.M114.573238

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Adenovirus E3/19K promotes evasion of NK cell recognition by intracellular sequestration of the NKG2D ligands major histocompatibility complex class I chain-related proteins A and B.

Authors:  Brian P McSharry; Hans-Gerhard Burgert; Douglas P Owen; Richard J Stanton; Virginie Prod'homme; Martina Sester; Katja Koebernick; Veronika Groh; Thomas Spies; Steven Cox; Ann-Margaret Little; Eddie C Y Wang; Peter Tomasec; Gavin W G Wilkinson
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

3.  Tumor-associated MICA is shed by ADAM proteases.

Authors:  Inja Waldhauer; Dennis Goehlsdorf; Friederike Gieseke; Toni Weinschenk; Mareike Wittenbrink; Andreas Ludwig; Stefan Stevanovic; Hans-Georg Rammensee; Alexander Steinle
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 4.  N-Glycans in cancer progression.

Authors:  Ken S Lau; James W Dennis
Journal:  Glycobiology       Date:  2008-08-13       Impact factor: 4.313

5.  ULBP6/RAET1L is an additional human NKG2D ligand.

Authors:  Robert A Eagle; James A Traherne; James R Hair; Insiya Jafferji; John Trowsdale
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

6.  Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.

Authors:  Tero Satomaa; Annamari Heiskanen; Iréne Leonardsson; Jonas Angström; Anne Olonen; Maria Blomqvist; Noora Salovuori; Caj Haglund; Susann Teneberg; Jari Natunen; Olli Carpén; Juhani Saarinen
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

7.  NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142.

Authors:  Omodele Ashiru; Neil J Bennett; Louise H Boyle; Mair Thomas; John Trowsdale; Mark R Wills
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.

Authors:  Nadia Guerra; Ying Xim Tan; Nathalie T Joncker; Augustine Choy; Fermin Gallardo; Na Xiong; Susan Knoblaugh; Dragana Cado; Norman M Greenberg; Norman R Greenberg; David H Raulet
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

9.  Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells.

Authors:  Lars Andresen; Karen Aagaard Hansen; Helle Jensen; Stine Falsig Pedersen; Peter Stougaard; Helle Rüsz Hansen; Jesper Jurlander; Søren Skov
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

10.  Human herpesvirus 7 u21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surface.

Authors:  Nathan A May; Nicole L Glosson; Amy W Hudson
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

View more
  12 in total

1.  Staphylococcus aureus induces cell-surface expression of immune stimulatory NKG2D ligands on human monocytes.

Authors:  Maiken Mellergaard; Rikke Illum Høgh; Astrid Lund; Blanca Irene Aldana; Romain Guérillot; Sofie Hedlund Møller; Ashleigh S Hayes; Nafsika Panagiotopoulou; Zofija Frimand; Stine Dam Jepsen; Camilla Hartmann Friis Hansen; Lars Andresen; Anders Rhod Larsen; Anton Y Peleg; Timothy P Stinear; Benjamin P Howden; Helle S Waagepetersen; Dorte Frees; Søren Skov
Journal:  J Biol Chem       Date:  2020-06-30       Impact factor: 5.157

2.  Limb girdle myasthenia with digenic RAPSN and a novel disease gene AK9 mutations.

Authors:  Ching-Wan Lam; Ka-Sing Wong; Ho-Wan Leung; Chun-Yiu Law
Journal:  Eur J Hum Genet       Date:  2016-12-14       Impact factor: 4.246

3.  Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD.

Authors:  Raphael Carapito; Nicolas Jung; Marius Kwemou; Meiggie Untrau; Sandra Michel; Angélique Pichot; Gaëlle Giacometti; Cécile Macquin; Wassila Ilias; Aurore Morlon; Irina Kotova; Petya Apostolova; Annette Schmitt-Graeff; Anne Cesbron; Katia Gagne; Machteld Oudshoorn; Bronno van der Holt; Myriam Labalette; Eric Spierings; Christophe Picard; Pascale Loiseau; Ryad Tamouza; Antoine Toubert; Anne Parissiadis; Valérie Dubois; Xavier Lafarge; Myriam Maumy-Bertrand; Frédéric Bertrand; Luca Vago; Fabio Ciceri; Catherine Paillard; Sergi Querol; Jorge Sierra; Katharina Fleischhauer; Arnon Nagler; Myriam Labopin; Hidetoshi Inoko; Peter A von dem Borne; Jürgen Kuball; Masao Ota; Yoshihiko Katsuyama; Mauricette Michallet; Bruno Lioure; Régis Peffault de Latour; Didier Blaise; Jan J Cornelissen; Ibrahim Yakoub-Agha; Frans Claas; Philippe Moreau; Noël Milpied; Dominique Charron; Mohamad Mohty; Robert Zeiser; Gérard Socié; Seiamak Bahram
Journal:  Blood       Date:  2016-08-22       Impact factor: 22.113

4.  MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.

Authors:  A Martinez-Chamorro; A Moreno; M Gómez-García; M J Cabello; J Martin; M Á Lopez-Nevot
Journal:  Clin Exp Immunol       Date:  2016-04-05       Impact factor: 4.330

Review 5.  The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies.

Authors:  Mar Valés-Gómez
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

6.  MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue.

Authors:  Hormas Ghadially; Lee Brown; Chris Lloyd; Leeanne Lewis; Arthur Lewis; Janette Dillon; Richard Sainson; Jelena Jovanovic; Natalie J Tigue; David Bannister; Lisa Bamber; Viia Valge-Archer; Robert W Wilkinson
Journal:  Br J Cancer       Date:  2017-03-23       Impact factor: 7.640

Review 7.  NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.

Authors:  Alexandra Frazao; Louise Rethacker; Meriem Messaoudene; Marie-Françoise Avril; Antoine Toubert; Nicolas Dulphy; Anne Caignard
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 8.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

9.  The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.

Authors:  Antje Isernhagen; Daniela Schilling; Sebastian Monecke; Pranali Shah; Leslie Elsner; Lutz Walter; Gabriele Multhoff; Ralf Dressel
Journal:  Immunogenetics       Date:  2015-11-19       Impact factor: 2.846

10.  Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.

Authors:  Sofie H Møller; Maiken Mellergaard; Mikkel Madsen; Amaia V Bermejo; Stine D Jepsen; Marie H Hansen; Rikke I Høgh; Blanca I Aldana; Claus Desler; Lene Juel Rasmussen; Elahu G Sustarsic; Zachary Gerhart-Hines; Evangelia Daskalaki; Craig E Wheelock; Thomas K Hiron; Da Lin; Christopher A O'Callaghan; Hans H Wandall; Lars Andresen; Søren Skov
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.